New Quicker Treatment for TB

The CDC announced today a new treatment for TB which takes one-third the time of current therapy. It also offers an effective treatment option for many patients at high risk for developing TB. Latent TB infections result from exposure to TB, without the contagion and illness caused by the disease itself.


New treatment for TB

Up to now, the regimen for latent TB infection was daily doses of a drug called isoniazid (INH). A total of 270 daily doses were taken over the course of nine months to eradicate the bacteria, which can lie dormant in the body for years. The new therapy is just twelve doses, given once-weekly, of INH combined with another TB drug called rifapentine was as effective. The shorter, weekly combination therapy is safe and effective, but perhaps the most important finding was the new therapy improved compliance by at least 10 percent.

The study was done in 8000 patients over 10 years to come up with this new treatment plan for TB.

Most people who develop symptoms of a TB infection first became infected in the past. However, in some cases, the disease may become active within weeks after the primary infection.  Symptoms include: cough, coughing up blood, sweats, fatigue, fever, unexplained weight loss, chest pain, difficulty breathing and wheezing. 7% of patients die from TB and with drug-resistant forms of TB it raises it to 50%.

About hightechnologyscrubs

I own and operate an online store that specializes in nursing scrubs, nursing uniforms, lab coats and clogs. The website includes New Balance, Gelscrubs, Jockey, Cherokee, Trend, White Swan, and the product line I am most proud of is a protecting fluid repelling scrub line from Vestex.
This entry was posted in health, Health Care, infectious disease and tagged , , , , , , , , . Bookmark the permalink.

1 Response to New Quicker Treatment for TB

  1. Now this is super exiciting! I only wonder how expensive this new treatment is, and whether it will be at all accessible to countries like South Africa, where the burden of disease is great and neither patients nor their government can afford expensive medication regimens.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s